Immunological Surveillance

Immune Surveillance deals with the issues regarding tumor immunology and surveillance, in which the central theme is all about the life span of the mammalian host that is depleted by the environment with mutagenic agents and solutions. The book is divided into six chapters. It includes discussions on the organization and modulation of cell membrane receptors, as well as the origin and expression of membrane antigens. It also covers the topics on the triggering mechanisms for and effector mechanisms activated by the cellular recognition. These topics analyze and evaluate alternatives for the recognition and destruction mechanisms in the knowledge of cell cooperation and requirements for immune recognition. A chapter provides discourse on a solution for the paradox of thriving tumors based on the demonstrable in vitro host immunity. Another discusses the generation of antibody diversity and the theory of self-tolerance. The last chapter explains the evaluation of the evidence for immune surveillance. This reference will be invaluable to those who specialize in immunology.

The Janeway's Immunobiology CD-ROM, Immunobiology Interactive, is included with each book, and can be purchased separately. It contains animations and videos with voiceover narration, as well as the figures from the text for presentation purposes.

Proceedings of the European Cooperation in the Field of Scientific and Technical Research (COST 825) Symposium on Mammary Gland Biology, held September 16-18, 1999, in Tours, France. It is difficult to overstate the evolutionary and functional significance of mammary tissue in biology. Substantial progress has been made by researchers in various disciplines, particularly over the last fifteen years, towards realizing the potential of this tissue to yield powerful experimental models for morphogenesis and tissue development; for cellular differentiation; for the biosynthesis and secretion of proteins, lipids, small molecules and inorganic salts; and for the coordination and regulation of these processes. More recently, the possibility of exploiting the secretory epithelial cells of mammary tissue as `cell factories' has become a reality and the recombinant production by lactating animals of an increasing number of proteins, valuable both in the pharmaceutical and `nutraceutical' fields, is in progress or under development. Also in this sphere of agricultural production, genetic as well as nutritional technologies are under investigation and exploitation to optimize milk composition for various end-uses - for instance in food process and manufacture. The possibilities of deriving health benefit from the bioactive properties of some of the minor constituents of milk are emerging to counter the highly-publicized negative health impact of excessive consumption of saturated animal fats. In human nutrition and medicine, the mammary gland is both a source of nutrition to the neonate and a potential health threat to the adult female - breast cancer remains the major single cause of female mortality in most developed countries. This volume provides a unique glimpse into our understanding, at the cutting edge of a variety of disciplines, of this versatile and extraordinary tissue, at the birth of the twenty-first century.

Since decades cancer immune surveillance is a topic of hot debates and there is still controversy about the role of the immune system in controlling tumor growth and eliminating transformed cells. For viral induced cancers it has been shown that the immune system is able to surveil tumor growth, but it remains unclear whether sporadic cancers are recognized by immune cells resulting in a destructive T cell response. This study investigated de novo T cell responses against a neoantigen expressed by cancer cells under non-acute inflammatory conditions. Therefore, a novel transplantation mouse model was established which closely simulated human sporadic cancer development. In this model, expression of the cancerdriving antigen and oncogene was tightly regulated by the Tet system. Cancer cells could be reversibly arrested after switching off the oncogene/antigen, but, surprisingly, the oncogene/antigen could be reexpressed at later time points in vitro and in vivo. By applying this model, the question at which time point during tumorigenesis the immune system interacts with nascent cancer cells was answered. Results of this study demonstrated that neoantigenspecific CD8^{+T cells were induced in the absence of acute inflammation and rejected nascent cancer cells thereby strongly arguing for existence of immune surveillance. The relevance of direct priming for inducing cytotoxic T cell responses against neoantigens expressed by sporadic cancer was confirmed by further experiments of this study.